Search Results - Conrad Fischer
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
-
6
A Structural Comparison of Oral SARS-CoV‑2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (Mpro) of SARS-CoV‑2 and MERS-CoV by Pu Chen, Tayla J. Van Oers, Elena Arutyunova, Conrad Fischer, Chaoxiang Wang, Tess Lamer, Marco J. van Belkum, Howard S. Young, John C. Vederas, M. Joanne Lemieux
Published in JACS Au (2024-07-01)Get full text
Article -
7
Prescription and efficacy of daclatasvir and sofosbuvir ± ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries:... by Stefan Bourgeois, Karel van Erpecum, Jean Delwaide, Uwe Naumann, Stefan Christensen, Christophe Moreno, Anita Pathil, Emile Schippers, Nancy van Emmerik, Benoit Caritey, Conrad Fischer, Florence Mercier, Joerg Petersen
Published in Cogent Medicine (2020-01-01)Get full text
Article -
8
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication by Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, Justin Shields, Holly A. Saffran, Ryan T. McKay, Marco J. van Belkum, Michael A. Joyce, Howard S. Young, D. Lorne Tyrrell, John C. Vederas, M. Joanne Lemieux
Published in Nature Communications (2020-08-01)Get full text
Article -
9
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication by Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, Justin Shields, Holly A. Saffran, Ryan T. McKay, Marco J. van Belkum, Michael A. Joyce, Howard S. Young, D. Lorne Tyrrell, John C. Vederas, M. Joanne Lemieux
Published in Nature Communications (2020-10-01)Get full text
Article
